Clinical TrialsJaypirca Regimen Cuts Progression Risk by 45% in Relapsed CLL Jaypirca Regimen Cuts Progression Risk by 45% in Relapsed CLL Read Post »
Clinical TrialsSun Pharma’s UNLOXCYT™ Delivers Durable Responses in Advanced CSCC Sun Pharma’s UNLOXCYT™ Delivers Durable Responses in Advanced CSCC Read Post »
Clinical TrialsSetmelanotide Lowers BMI and Improves Hyperphagia in Prader-Willi Syndrome Setmelanotide Lowers BMI and Improves Hyperphagia in Prader-Willi Syndrome Read Post »
Clinical TrialsAgios Presents Phase 3 RISE UP Results for Mitapivat in Sickle Cell Disease... Agios Presents Phase 3 RISE UP Results for Mitapivat in Sickle Cell Disease... Read Post »
Clinical TrialsfrontMIND Trial Meets Primary Endpoint in High-Risk DLBCL and HGBL frontMIND Trial Meets Primary Endpoint in High-Risk DLBCL and HGBL Read Post »
New Drug ApprovalFDA Approves New KEYTRUDA-WELIREG Regimen to Prevent Kidney Cancer Recurren... FDA Approves New KEYTRUDA-WELIREG Regimen to Prevent Kidney Cancer Recurren... Read Post »
New Drug ApprovalUK Approves Europe’s First Oral Wegovy for Weight Management UK Approves Europe’s First Oral Wegovy for Weight Management Read Post »
New Drug ApprovalAkeso Secures NMPA Approval for Gumokimab in Moderate-to-Severe Plaque Psor... Akeso Secures NMPA Approval for Gumokimab in Moderate-to-Severe Plaque Psor... Read Post »
Drugs Safety AlertPRAC Finds Inconsistent Evidence on Paternal Valproate Risk in Children PRAC Finds Inconsistent Evidence on Paternal Valproate Risk in Children Read Post »
Clinical TrialsNovartis’ Rhapsido Delivers Positive Phase 3 Results in CIU Novartis’ Rhapsido Delivers Positive Phase 3 Results in CIU Read Post »
Clinical TrialsCogent Advances Bezuclastinib Toward NDA Submission With Positive APEX Resu... Cogent Advances Bezuclastinib Toward NDA Submission With Positive APEX Resu... Read Post »
Clinical TrialsJazz’s Phase 3 LAGOON Trial Fails to Improve Survival in Relapsed SCL... Jazz’s Phase 3 LAGOON Trial Fails to Improve Survival in Relapsed SCL... Read Post »
Clinical TrialsVenetoclax Plus Obinutuzumab Cuts Risk of Progression or Death by 50% in CL... Venetoclax Plus Obinutuzumab Cuts Risk of Progression or Death by 50% in CL... Read Post »
Clinical TrialsGenmab’s Epcoritamab Plus R2 Maintains Strong Benefit Across Risk Gro... Genmab’s Epcoritamab Plus R2 Maintains Strong Benefit Across Risk Gro... Read Post »
Clinical TrialsCullinan Reports Promising Phase 1 Results for CLN-978 and Velinotamig Cullinan Reports Promising Phase 1 Results for CLN-978 and Velinotamig Read Post »
Clinical TrialsFDA Backs Phase 3 Plan as Enliven Posts Strong Phase 1 CML Results FDA Backs Phase 3 Plan as Enliven Posts Strong Phase 1 CML Results Read Post »
Clinical TrialsZiftomenib + 7+3 Achieves 94% One-Year Survival in NPM1-Mutant AML in KOMET... Ziftomenib + 7+3 Achieves 94% One-Year Survival in NPM1-Mutant AML in KOMET... Read Post »
Clinical TrialsSix-Year SEQUOIA Data Highlight Durable BRUKINSA Benefit in CLL Patients Ag... Six-Year SEQUOIA Data Highlight Durable BRUKINSA Benefit in CLL Patients Ag... Read Post »
Clinical TrialsJohnson & Johnson Strengthens IMAAVY FDA Filing With Positive ENERGY Re... Johnson & Johnson Strengthens IMAAVY FDA Filing With Positive ENERGY Re... Read Post »
New Drug ApprovalFDA Expands Organon’s TOFIDENCE Biosimilar Approval to CAR-T CRS and COVI... FDA Expands Organon’s TOFIDENCE Biosimilar Approval to CAR-T CRS and COVI... Read Post »
Drugs Safety AlertFDA Updates Alli Label to Warn of Rare Risk of Acute Kidney Injury and Kidn... FDA Updates Alli Label to Warn of Rare Risk of Acute Kidney Injury and Kidn... Read Post »
Clinical TrialsSanofi Halts Phase 3 MOBILIZE Trial of Riliprubart in Refractory CIDP Sanofi Halts Phase 3 MOBILIZE Trial of Riliprubart in Refractory CIDP Read Post »
Clinical TrialsFDA Aligns on Phase 3 Design for Alterity’s ATH434 in MSA FDA Aligns on Phase 3 Design for Alterity’s ATH434 in MSA Read Post »
New Drug ApprovalFDA Approves Every-8-Week EBGLYSS Dosing for Atopic Dermatitis FDA Approves Every-8-Week EBGLYSS Dosing for Atopic Dermatitis Read Post »
New Drug ApprovalFDA Adds Bemotrizinol to OTC Sunscreen Monograph, First New UV Filter in Ov... FDA Adds Bemotrizinol to OTC Sunscreen Monograph, First New UV Filter in Ov... Read Post »
Clinical TrialsTango Sets Phase 3 Course for Vopimetostat-Daraxonrasib in MTAP-Deleted PDA... Tango Sets Phase 3 Course for Vopimetostat-Daraxonrasib in MTAP-Deleted PDA... Read Post »
New Drug ApprovalMHRA Grants Authorization for Nipocalimab in gMG MHRA Grants Authorization for Nipocalimab in gMG Read Post »
Clinical Trials82% of Patients Respond to BRIUMVI in Early Myasthenia Gravis Study 82% of Patients Respond to BRIUMVI in Early Myasthenia Gravis Study Read Post »
Clinical TrialsGilead and Merck’s Once-Weekly HIV Pill Meets Phase 3 Goals Gilead and Merck’s Once-Weekly HIV Pill Meets Phase 3 Goals Read Post »
Clinical TrialsLilly’s Oral GLP-1 Foundayo Shows Clear Edge Over Oral Semaglutide Lilly’s Oral GLP-1 Foundayo Shows Clear Edge Over Oral Semaglutide Read Post »
Clinical TrialsElecoglipron Lowers HbA1c by 1.9% and Drives Weight Loss in Phase 2b Studie... Elecoglipron Lowers HbA1c by 1.9% and Drives Weight Loss in Phase 2b Studie... Read Post »
Clinical TrialsSurvodutide Delivers Up to 16.6% Weight Loss and Reduces Liver Fat in Phase... Survodutide Delivers Up to 16.6% Weight Loss and Reduces Liver Fat in Phase... Read Post »
ResearchINGREZZA Delivered Rapid Tardive Dyskinesia Improvement in Patients With ID... INGREZZA Delivered Rapid Tardive Dyskinesia Improvement in Patients With ID... Read Post »
Clinical TrialsCullinan Therapeutics Delivers CLN-978 Remission in Lupus and RA Cullinan Therapeutics Delivers CLN-978 Remission in Lupus and RA Read Post »
Clinical TrialsCagriSema Delivers Superior HbA1c and Weight Reduction Across Phase 3 REIMA... CagriSema Delivers Superior HbA1c and Weight Reduction Across Phase 3 REIMA... Read Post »
New Drug ApprovalEU Approves Sarclisa On-Body Injector Option for Multiple Myeloma EU Approves Sarclisa On-Body Injector Option for Multiple Myeloma Read Post »
New Drug ApprovalFDA Approves HYMPAVZI for Children and Hemophilia Patients With Inhibitors FDA Approves HYMPAVZI for Children and Hemophilia Patients With Inhibitors Read Post »
Clinical TrialsMazdutide Extends Lead Over Semaglutide in Detailed DREAMS-3 Results Mazdutide Extends Lead Over Semaglutide in Detailed DREAMS-3 Results Read Post »
Clinical TrialsSemaglutide Cuts Sleep Apnea Risk and Improves Cardiometabolic Health in Ne... Semaglutide Cuts Sleep Apnea Risk and Improves Cardiometabolic Health in Ne... Read Post »
Clinical TrialsRepatha Cuts Cardiovascular Events by 29% in High-Risk Diabetes Subgroup Repatha Cuts Cardiovascular Events by 29% in High-Risk Diabetes Subgroup Read Post »
Clinical TrialsRetatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Retatrutide Delivers Up to 28.3% Weight Loss and Improves Obesity-Related C... Read Post »
Clinical TrialsAmneal Reports Positive Interim Result for CREXONT® in PD Amneal Reports Positive Interim Result for CREXONT® in PD Read Post »
Clinical TrialsNovo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Novo Nordisk Reports Strong Real-World Outcomes With Semaglutide 2 mg Escal... Read Post »
Clinical TrialsPfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Pfizer’s Berobenatide Delivers Up to 15.9% Weight Loss, Supports Broa... Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN AstraZeneca Reports Positive Phase III Results for Ultomiris in IgAN Read Post »
Clinical TrialsMannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... MannKind Reports New Afrezza Findings Across Pediatric and Adult Diabetes P... Read Post »
Clinical Trials Disease & DrugsInnovent’s Mazdutide Cuts BMI by Up to 11% in Adolescents with Obesity, A... Innovent’s Mazdutide Cuts BMI by Up to 11% in Adolescents with Obesity, A... Read Post »
Clinical TrialsNovo Nordisk’s Zenagamtide Lowers HbA1c by Up to 1.7% and Delivers 14.6% ... Novo Nordisk’s Zenagamtide Lowers HbA1c by Up to 1.7% and Delivers 14.6% ... Read Post »
Clinical TrialsBayer Reports Broad CKD Benefits with Finerenone in INFINITY Analysis Bayer Reports Broad CKD Benefits with Finerenone in INFINITY Analysis Read Post »
New Drug ApprovalNMPA Approves Lupeng’s Rocbrutinib, China’s First Fourth-Generation... NMPA Approves Lupeng’s Rocbrutinib, China’s First Fourth-Generation... Read Post »
